BioSignal

⚡ Gain Your Competitive Edge. Limited Seats Available

Get ahead with clinical intelligence institutional investors rely on. Apply now

Clinical Trial Intelligence for Institutional Investors

Find the signal. Clinical trial intelligence to help you predict which trials will lead to successful new medicines.

View Plans

Platform Capabilities

Enterprise-grade tools for clinical analysis

Trial Success Prediction

Probability-weighted PTRS scores and Monte Carlo simulations — predict which trials are most likely to succeed before data readout.

Competitive Landscape

Understand competitor activity and market positioning by indication

Catalyst Intelligence

Key dates, PDUFA deadlines, and regulatory milestones — never miss a binary event.

Regulatory Risk Analysis

FDA pathway analysis, AdCom precedents, and delta analysis to flag aggressive timelines.

Trusted Data Sources

Powered by official regulatory and clinical databases

ClinicalTrials.gov

Official U.S. clinical trial registry

FDA Databases

Regulatory approval and pathway data

SEC EDGAR

Company filings and financial disclosures

Ready to analyze clinical pipelines?

Access institutional-grade clinical intelligence for your investment decisions.

See All Plans

BioSignal is a product of RGA Investment Advisors, LLC, a registered investment adviser with the Securities and Exchange Commission. Nothing contained in this platform constitutes investment advice, a recommendation, or an offer to buy or sell any security. Your access to and use of the BioSignal platform does not establish, create, or constitute an advisory relationship between you and RGA Investment Advisors, LLC, nor does it constitute an engagement by RGA Investment Advisors, LLC to advise on or manage your assets. For the full terms of use and disclaimers, please refer to our Terms of Use.

© 2026 RGA Investment Advisors, LLC. All rights reserved.